Couverture de eHIV Review

eHIV Review

eHIV Review

De : eHIV Review
Écouter gratuitement

À propos de ce contenu audio

Expert insight and analysis providing information directly relevant to HIV care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

Hosted on Acast. See acast.com/privacy for more information.

DKBmed 2019
Hygiène et vie saine Maladie et pathologies physiques
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Youth & HIV: Understanding the Unique Challenges
      Dec 3 2025

      In this issue we focus on youth: the 13 to 24-year-old population responsible for nearly 20% of new HIV diagnoses in the US. Their entry into the HIV care continuum has been slow, hindered by barriers that are just now beginning to be recognized and overcome. What’s been done, what’s being done, and what needs to be done to better educate and motivate this critically important under-diagnosed and under-treated community?

      Join Dr. David C. Griffith from the Departments of Medicine and Pediatrics at the Johns Hopkins University School of Medicine in Baltimore, as he shares his knowledge and expertise in identifying and managing youth at risk for becoming infected, as well as those already living with, HIV — in this issue of eHIV Review.

      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      25 min
    • Managing HIV-Related Comorbidities in an Aging Population
      Sep 30 2025

      PWH. People living with HIV. They’re growing older. And they’re experiencing the same illnesses of aging — CVD, kidney and liver diseases, cancers — as their HIV-seronegative counterparts.

      The question is: how should they be treated?

      Should the comorbidities of aging PWH be managed with the same agents and dosing regimens as people the same age who have not been fighting a chronic infective condition? How do the treatments that have increased PWH wellness and expected lifespans affect the safety and efficacy of the preferred comorbidity management options? What does the evidence-based data say?

      Join Dr. Maile Young Karris, Co-Director of the San Diego Center for AIDS Research Clinical Investigations Core, and an Associate Professor from the Department of Medicine at the University of California in San Diego, as we discuss strategies to mitigate the effects of comorbidities in older people living with HIV — in this issue of eHIV Review.

      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      24 min
    • Overcoming Barriers to PrEP in Rural America
      Aug 14 2025

      PrEP. For most patients, that’s a simple drug regimen that can be prescribed after a negative HIV screen. Safe. Effective. Proactive protection to stop the spread of HIV infection in MSM, cisgender, and transgender individuals.


      Post-test for CME credits: https://elit.dkbmed.com/issues/228/test

      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      31 min
    Aucun commentaire pour le moment